Compounds > dabigatran

Page last updated: 2024-09-05

dabigatran and Vascular Malformations

dabigatran has been researched along with Vascular Malformations in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Chen, H; Gu, H; Hu, L; Lin, X; Liu, H; Xu, Z; Yang, X	1
Ahmed, H; Mushahid, H; Shah, SA	1
Ishiura, R; Narushima, M; Yasumoto, A; Yatomi, Y	1
Binet, Q; Hermans, C; Lambert, C	1
Ardillon, L; Boon, LM; Eeckhoudt, S; Hermans, C; Lambert, C	1

Other Studies

5 other study(ies) available for dabigatran and Vascular Malformations

Article	Year
Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations. Journal of vascular surgery. Venous and lymphatic disorders, 2023, Volume: 11, Issue:2 Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Child; Dabigatran; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Pain; Retrospective Studies; Vascular Malformations	2023
Dabigatran for venous malformations: A call for a stringent approach. Journal of vascular surgery. Venous and lymphatic disorders, 2023, Volume: 11, Issue:5 Topics: Dabigatran; Humans; Vascular Diseases; Vascular Malformations	2023
Successful treatment with dabigatran for consumptive coagulopathy associated with extensive vascular malformations. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2017, Volume: 28, Issue:8 Topics: Adolescent; Anemia; Antithrombins; Atrial Fibrillation; Dabigatran; Disseminated Intravascular Coagulation; Erythrocyte Transfusion; Female; Humans; Treatment Outcome; Vascular Malformations	2017
Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations. Thrombosis research, 2018, Volume: 168 Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Dabigatran; Female; Humans; Vascular Malformations; Young Adult	2018
Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2016, Volume: 27, Issue:2 Topics: Adult; Anticoagulants; Blood Platelets; Dabigatran; Disseminated Intravascular Coagulation; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Platelet Count; Thrombosis; Vascular Malformations	2016